Filing Details

Accession Number:
0001213900-16-019534
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-20 10:02:05
Reporting Period:
2016-12-16
Filing Date:
2016-12-20
Accepted Time:
2016-12-20 10:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1068029 J Christopher Schaber 29 Emmons Drive, Suite C-10
Princeton NJ 08540
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-16 15,804 $3.16 25,095 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2016-12-16 19,755 $0.00 19,755 $3.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,755 2016-12-16 2021-12-15 No 4 P Direct